°øÀ¯Çϱâ
½ÉÇ÷°ü ÁßÀç½Ã¼ú ¸Å´º¾ó °³Á¤ÆÇ
±¸¸ÅÈıâ 0°³ (0)
¤ýµµ¼­Á¤º¸ ÀúÀÚ : ´ëÇѽÉÇ÷°ü±â¼ú¿¬±¸È¸
ÃâÆÇ»ç : ¿ì¸®ÀÇÇм­Àû
2025³â 04¿ù 30ÀÏ Ãâ°£  |  ISBN : 1185658831  |  464ÂÊ
¤ý±³º¸È¸¿ø ±³º¸¹®°í ID ¿¬°áÇϱâ
µµ¼­¸¦ ±¸ÀÔÇÏ½Ã¸é ±³º¸¹®°í¿Í ²É¸¶ÀÇ È¸¿øÇýÅÃÀ» ÇÔ²²
¹ÞÀ¸½Ç ¼ö ÀÖ½À´Ï´Ù.
¤ý²É¸¶°¡ 60,000¿ø
¤ýÃß°¡ÇýÅà ²É 3¼ÛÀÌ
²É¼ÛÀÌÁö°© ¸¸µé±â>
²É¼ÛÀÌ Àû¸³À» À§Çؼ­ '²É¼ÛÀÌÁö°©'À» ¸¸µå¼Å¾ß ÇÕ´Ï´Ù.
¤ý¹è¼ÛÁö¿ª ±¹³»
¤ý¹è¼Ûºñ
Á¶°ÇºÎ¹«·á¹è¼Û
  • ÀÌ °¡°ÔÀÇ ¹«·á¹è¼Û »óǰÀ» ÇÔ²² ÁÖ¹®Çϰųª, ÃÑÁÖ¹®±Ý¾×ÀÌ 15,000¿ø ÀÌ»óÀÌ¸é ¹«·á¹è¼Û.
  • 15,000¿ø ¹Ì¸¸ÀÌ¸é ¹è¼Ûºñ 2,500¿ø °í°´ºÎ´ã
  • µµ¼­»ê°£/Á¦ÁÖµµ´Â Ãß°¡¿îÀÓºñ ºÎ°úµÉ ¼ö ÀÖÀ½
1ÀÏ À̳» Ãâ°í
¤ý¼ö·®
ÃÑ ÇÕ°è±Ý¾×  ¿ø
Âò
¼±¹°
Àå¹Ù±¸´Ï ´ã±â
¹Ù·Î ±¸¸ÅÇϱâ

Àå¹Ù±¸´Ï¿¡ ´ã¾Ò½À´Ï´Ù. Àå¹Ù±¸´Ï¸¦ È®ÀÎ ÇϽðڽÀ´Ï±î?

¼îÇΰè¼ÓÇϱâ
Àå¹Ù±¸´Ïº¸±â
¤ýÀÌ °¡°ÔÀÇ ´Ù¸¥ »óǰ ¸ðµç»óǰº¸±â+
22,000¿ø
19,800¿ø 10%¡é
18,000¿ø
16,200¿ø 10%¡é
21,900¿ø
19,710¿ø 10%¡é
12,000¿ø
10,800¿ø 10%¡é
²ÞÀ» ÇÇ¿ì´Â ¼¼»ó, ÀÎÅÍ³Ý ±³º¸¹®°íÀÔ´Ï´Ù.
²ÞÀ» ÇÇ¿ì´Â ¼¼»ó, ÀÎÅÍ³Ý ±³º¸¹®°íÀÔ´Ï´Ù.
°¡°ÔÁÖÀÎ : ±³º¸¹®°í
ÀüÈ­ ¹× ÅùèÁ¤º¸
ÀüÈ­ ¹× ÅùèÁ¤º¸
»óǰ ¾È³» ¹× ȯºÒ, ±³È¯, ¹è¼Û¹®ÀÇ
- °¡°Ô ÀüÈ­¹øÈ£ : 1544-1900
- ÀüÈ­¹®ÀÇ ½Ã°£ : ¿ÀÀü 9½ÃºÎÅÍ ¿ÀÈÄ 6½Ã±îÁö
(¸ÅÁÖ ¿ù¿äÀÏ, È­¿äÀÏ, ¼ö¿äÀÏ, ¸ñ¿äÀÏ, ±Ý¿äÀÏ, °øÈÞÀÏ Á¦¿Ü)
- °¡°Ô À̸ÞÀÏ : ink@kyobobook.co.kr
- ÀÌ¿ë Åùèȸ»ç : CJ´ëÇÑÅë¿î
ÆÇ¸Å°¡°ÔÁ¤º¸
- »ç¾÷ÀÚ¸í : (ÁÖ)±³º¸¹®°í
- »ç¾÷ÀÚµî·Ï¹øÈ£ : 102-81-11670
- Åë½ÅÆÇ¸Å¾÷½Å°í : 01-0653
- Çö±Ý¿µ¼öÁõ : ¹ß±Þ°¡´É
ÀüÈ­ÁÖ¹® ¹× °áÁ¦¹®ÀÇ
- ²ÉÇÇ´Â ¾ÆÄ§¸¶À» : 1644-8422
°¡°Ô¿Í Á÷°Å·¡¸¦ ÇÏ½Ã¸é ²É¼ÛÀÌ Àû¸³ ¹× °¢Á¾ ÇýÅÿ¡¼­
Á¦¿ÜµÇ°í, ¸¸ÀÏÀÇ ¹®Á¦°¡ ¹ß»ýÇÏ´Â °æ¿ì¿¡µµ ²É¸¶ÀÇ
µµ¿òÀ» ¹ÞÀ¸½Ç ¼ö ¾ø½À´Ï´Ù. °¡°ÔÀÇ ºÎ´çÇÑ ¿ä±¸,
ºÒ°øÁ¤ ÇàÀ§ µî¿¡ ´ëÇØ¼­µµ ²É¸¶·Î Á÷Á¢ ÀüÈ­ÁÖ¼¼¿ä.
 À̾߱â²É¹ç
µî·ÏµÈ À̾߱Ⱑ ¾ø½À´Ï´Ù.
»ó¼¼Á¤º¸ ±¸¸ÅÈıâ (0°³)
(0)
»óǰ Q&A (0) ¹è¼Û/±³È¯/ȯºÒ ¾È³»

Ã¥¼Ò°³

2025³â 04¿ù 30ÀÏ Ãâ°£ | ISBN : 1185658831 | 464ÂÊ

¸ñÂ÷

CHAPTER 1_ Imaging & Physiology 1. Imaging ¨ç OCT ±¤°£¼·´ÜÃþÃÔ¿µ 2 ¨è IVUS(NIRS) Ç÷°ü³» ÃÊÀ½ÆÄ 26 2. Physiology ¨ç FFR ºÐȹÇ÷·ù¿¹ºñ·Â 68 ¨è IMR(¹Ì¼¼Ç÷°ü ÀúÇ×ÁöÇ¥), CFR(°ü»óµ¿¸Æ Ç÷·ù ¿¹ºñ·Â), Non-hyperaemic pressure ratios(ºñÃæÇ÷¾Ð·Âºñ) 88 CHAPTER 2_ Special Device modalities 1. ROTA ȸÀü Á×Á¾Á¦°Å¼ú 100 2. ECMO ü¿Ü¸·»ê¼ÒÈ­ÀåÄ¡ 118 3. PCC(Pericardiocentesis) ½É³¶ õÀÚ 142 4. TPM(Temporary Pacemaker) ÀÓ½ÃÇü ½É¹Úµ¿±â 145 5. Cardioversion & Defibrillation ½ÉÀ²µ¿Àüȯ°ú Á¦¼¼µ¿ 156 6. EMB(Endomyocardial Biopsy) ½É³»¸· »ý°Ë 161 CHAPTER 3_ SHD (Structural Heart Disease) ±¸Á¶Àû ½ÉÀåÁúȯ 1 ¼±Ãµ¼º ½ÉÁúȯ(ASD, PFO, PDA, LAAO) ¨ç ½É¹æÁ߰ݰá¼Õ(Atrial Septal Defect, ASD) & ³­¿ø°ø °³Á¸(Patent Foramen Ovale, PFO) 166 ¨è µ¿¸Æ°ü °³Á¸Áõ(Patent Ductus Arteriosus, PDA) 179 ¨é Á½ɹæÀÌ Æó»ö¼ú(Left Atrial Appendage Occlusion, LAAO) 189 2. TAVI(Edward, Medronic, Boston) °æÇÇÀû´ëµ¿¸ÆÆÇ¸·Ä¡È¯¼ú 199 3. ICE ½ÉÀå³»ÃÊÀ½ÆÄ 229 CHAPTER 4_ Peripheral Intervention 1. EVAR & TEVAR º¹ºÎ¡¤ÈäºÎ´ëµ¿¸Æ ½ºÅÙÆ® »ðÀÔ¼ú 252 2. PTA(Percutaneous Transluminal Angioplasty) ¸»ÃÊÇ÷°üÁßÀç½Ã¼ú 263 3. Peripheral Device(JETSTREAM, ȣũ¿ø, ¿£Áö¿ÀÁ¬) 281 4. Closing Device(Perclose Prostyle, Femoseal, Mynx, Exoseal, Angioseal¡¦) 297 CHAPTER 5_ ½ÉÀå Ä«Å×ÅÍ °Ë»ç 1. Cardiac catheterization ½ÉµµÀÚ¼ú 310 2. CTEPH & BPA ¸¸¼º Ç÷Àü»öÀü¼º Æó°íÇ÷¾Ð 319 CHAPTER 6_ ½ÉÇ÷°ü ÁßÀç½Ã¼ú ȯÀÚ °£È£Interventional cardiovascular nursingInterventional cardiovascular nursing 1. CAG(Coronary angiography) °ü»óµ¿¸Æ Á¶¿µ¼úÇö»ó 326 2. PCI(Percutaneous Coronary Intervention) °æÇÇÀû °ü»óµ¿¸Æ ÁßÀç¼ú 337 3. CAG, PCI ±Þ¿©±âÁØ(¿ä¾ç±Þ¿©ºñ¿ëÀÇ »êÃâ ¹æ¹ý) 345 4. Spasm Provocation Test Ç÷°ü °æ·Ã À¯¹ß °Ë»ç 362 CHAPTER 7_ Procedural complications ½Ã¼ú ÇÕº´Áõ 1. No reflow phenomenon ¹«°ü·ù Çö»ó 370 2. Coronary artery perforation °ü»óµ¿¸Æ õ°ø 374 3. Coronary artery dissection & Acute closure °ü»óµ¿¸Æ ¹Ú¸® ¹× ±Þ¼º Æó¼â 378 4. Local vascular complications ±¹¼ÒÇ÷°ü ÇÕº´Áõ 382 5. Acute myocardial infarction ±Þ¼º ½É±Ù°æ»ö Fast track(C¡Ú) ¹× CPCR 386 6. Unstable vital signs ºÒ¾ÈÁ¤ÇÑ È°·Â¡ÈÄ 390 7. Transfusion reaction ¼öÇ÷ ºÎÀÛ¿ë 396 8. Contrast media reactions Á¶¿µÁ¦ ºÎÀÛ¿ë 400 9. Contrast Induced Nephropathy Á¶¿µÁ¦ À¯¹ß ½Åµ¶¼º 404 10. CAG & PCI ÇÕº´Áõ 407 CHAPTER 8_ Cardiovascular Drugs ½ÉÇ÷°ü°è ¾à¹° 1. Anticoagulant agents Ç×ÀÀ°íÁ¦ 416 2. Antiplatelet agents Ç×Ç÷¼ÒÆÇÁ¦ 421 3. DAPT(Dual Antiplatelet Therapy) ÀÌÁßÇ×Ç÷¼ÒÆÇ¿ä¹ý 428 4. Thrombolytic agents Ç÷Àü¿ëÇØÁ¦ 435 5. Anti-ischemic therapy Ç×ÇãÇ÷ Ä¡·á 440 Index / 446

ÃâÆÇ»ç ¼­Æò

´ëÇѽÉÇ÷°ü±â¼ú¿¬±¸È¸ Text bookÀ» °³Á¤Çϸç... À̹ø ¡°KCTA ½ÉÇ÷°ü ÁßÀç½Ã¼ú ¸Å´º¾ó¡± °³Á¤ÆÇÀº Çö´ë ÀÇ·á ºÐ¾ß¿¡¼­ Áß¿äÇÑ À§Ä¡¸¦ Â÷ÁöÇÏ´Â ½ÉÇ÷°ü Áúȯ ¹× ½Ã¼ú¿¡ ´ëÇÑ Æ÷°ýÀûÀÎ ÃֽŠÁ¤º¸¸¦ Á¦°øÇϱâ À§ÇØ ÆíÂù °³Á¤µÇ¾ú½À´Ï´Ù. ½ÉÇ÷°ü ºÐ¾ßÀÇ Ãֽбâ¼ú°ú ¿¬±¸¸¦ ¹ßÀü½Ã۱â À§ÇÑ ³ë·ÂÀ¸·Î ¹æ»ç¼±»ç, ÀÓ»óº´¸®»ç, °£È£»ç ¼±»ý´Ôµé°ú ÀÌ ºÐ¾ß¿¡ °ü½ÉÀÖ´Â ÇлýµéÀÌ ÃֽŠÁ¤º¸¿¡ Á¢±ÙÇϰí Àû¿ëÇÒ ¼ö ÀÖµµ·Ï °³Á¤µÇ¾ú½À´Ï´Ù. À̹ø °³Á¤ÆÇÀº Àü±¹ ¿©·¯ º´¿ø ½ÉÇ÷°ü ½Ã¼ú½Ç¿¡¼­ ±Ù¹«ÇÏ´Â ¼±»ý´ÔµéÀÌ 3³â¿¡ °ÉÃÄ ¼ö½Ê³âÀÇ ³ëÇϿ츦 °øÀ¯ÇØÁֽб׾ߏ»·Î Á¤¿­À» ½ñÀº ´ëÀÛÀ̶ó°í Ç¥ÇöÇÏ°í ½Í½À´Ï´Ù. KCTA ½ÉÇ÷°ü ÁßÀç½Ã¼ú ¸Å´º¾ó ÃÊÆÇÀÌ ³ª¿Â ÈÄ¿¡ °³Á¤ÆÇÀ» ¹ß°£ÇÏ°Ô µÅ¼­ °¨È¸°¡ ±í½À´Ï´Ù. ÀڷḦ ¼öÁýÇϰí Á¤¸®ÇØÁֽŠÁýÇÊÁø ¼±»ý´Ôµé ÇѺРÇѺв² ±íÀº °¨»ç¸¦ µå¸®¸ç ÀÌ Ã¥ÀÇ ¹ß°£¿¡ ±â¿©ÇÑ ¿ì¸®ÀÇÇм­Àû ÃâÆÇ»ç Á÷¿øµé ¸ðµÎ¿¡°Ôµµ ´Ù½ÃÇѹø °¨»çµå¸³´Ï´Ù. ÀÌ Ã¥À» º¸½Ã´Â µ¶ÀÚ ¿©·¯ºÐ¿¡°Ô µµ¿òÀÌ µÇ±æ ¹Ù¶ó°í, ÆíÁýÁø°ú ±â¿©Àڵ鿡 ´ëÇÑ Á¸°æ°ú °¨»çÀÇ ¸¶À½À» Ç¥ÇÕ´Ï´Ù. 2025³â 1¿ù 10ÀÏ ´ëÇѽÉÇ÷°ü±â¼ú¿¬±¸È¸ ȸÀå °­ ÁØ ¿ø
±¸¸ÅÈıâ
ÀÌ »óǰ¿¡ ´ëÇÑ ±¸¸ÅÈıâ´Â ±¸¸ÅÇϽŠºÐ¿¡ ÇÑÇØ 'ÁÖ¹®/¹è¼ÛÁ¶È¸'¿¡¼­ ÀÛ¼ºÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
¸¸Á·µµ¼ø
Ãֽżø
ÀÛ¼ºµÈ ±¸¸ÅÈıⰡ ¾ø½À´Ï´Ù.
    »óǰQ&A
    »óǰ¿¡ °üÇÑ ±Ã±ÝÇϽŠ»çÇ×À» ¹°¾îº¸¼¼¿ä!
    ±Û¾²±â
    ±Û¾²±â
      ¹è¼Û/±³È¯/ȯºÒ ¾È³»
      ¹è¼Û¾È³»
      - ÁÖ¹®±Ý¾×ÀÌ 15,000¿ø ÀÌ»óÀÎ °æ¿ì ¹«·á¹è¼Û, 15,000 ¹Ì¸¸ÀÎ °æ¿ì ¹è¼Ûºñ 2,500¿øÀÌ ºÎ°úµË´Ï´Ù. (´Ü, ¹«·á¹è¼Û »óǰÀÇ °æ¿ì Á¦¿Ü)
      - ÁÖ¹® ÈÄ ¹è¼ÛÁö¿ª¿¡ µû¶ó ±¹³» ÀϹÝÁö¿ªÀº ±Ù¹«ÀÏ(¿ù-±Ý) ±âÁØ 1Àϳ» Ãâ°íµÊÀ» ¿øÄ¢À¸·Î Çϳª, ±â»ó»óȲ µîÀÇ ÀÌÀ¯·Î Áö¿¬µÉ ¼öµµ ÀÖ½À´Ï´Ù. (´Ü, ÀÏ¿äÀÏ ¹× °øÈÞÀÏ¿¡´Â ¹è¼ÛµÇÁö ¾Ê½À´Ï´Ù.)
      - µµ¼­ »ê°£ Áö¿ª ¹× Á¦ÁÖµµÀÇ °æ¿ì´Â Ç×°ø/µµ¼± Ãß°¡¿îÀÓÀÌ ºÎ°úµÉ ¼ö ÀÖ½À´Ï´Ù.
      - ÇØ¿ÜÁö¿ªÀ¸·Î´Â ¹è¼ÛµÇÁö ¾Ê½À´Ï´Ù.
      ±³È¯/ȯºÒ ¾È³»
      - »óǰÀÇ Æ¯¼º¿¡ µû¸¥ ±¸Ã¼ÀûÀÎ ±³È¯ ¹× ȯºÒ±âÁØÀº °¢ »óǰÀÇ '»ó¼¼Á¤º¸'¸¦ È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
      - ±³È¯ ¹× ȯºÒ½ÅûÀº °¡°Ô ¿¬¶ôó·Î ÀüÈ­ ¶Ç´Â À̸ÞÀÏ·Î ¿¬¶ôÁֽøé ÃÖ¼±À» ´ÙÇØ ½Å¼ÓÈ÷ ó¸®ÇØ µå¸®°Ú½À´Ï´Ù.

      ±³È¯ ¹× ȯºÒ °¡´É »óǰ¿¡
      ¹®Á¦°¡ ÀÖÀ» °æ¿ì
      1) »óǰÀÌ Ç¥½Ã/±¤°íµÈ ³»¿ë°ú ´Ù¸£°Å³ª ºÒ·®(ºÎÆÐ, º¯Áú, ÆÄ¼Õ, Ç¥±â¿À·ù, À̹°È¥ÀÔ, Áß·®¹Ì´Þ)ÀÌ ¹ß»ýÇÑ °æ¿ì
      - ½Å¼±½Äǰ, ³ÃÀå½Äǰ, ³Ãµ¿½Äǰ : ¼ö·ÉÀÏ ´ÙÀ½³¯±îÁö ½Åû
      - ±âŸ »óǰ : ¼ö·ÉÀϷκÎÅÍ 30ÀÏ À̳», ±× »ç½ÇÀ» ¾È ³¯ ¶Ç´Â ¾Ë ¼ö ÀÖ¾ú´ø ³¯·ÎºÎÅÍ 30ÀÏ À̳» ½Åû
      2) ±³È¯ ¹× ȯºÒ½Åû ½Ã ÆÇ¸ÅÀÚ´Â »óǰÀÇ »óŸ¦ È®ÀÎÇÒ ¼ö ÀÖ´Â »çÁøÀ» ¿äûÇÒ ¼ö ÀÖÀ¸¸ç »óǰÀÇ ¹®Á¦ Á¤µµ¿¡ µû¶ó Àç¹è¼Û, ÀϺÎȯºÒ, ÀüüȯºÒÀÌ ÁøÇàµË´Ï´Ù. ¹Ýǰ¿¡ µû¸¥ ºñ¿ëÀº ÆÇ¸ÅÀÚ ºÎ´ãÀ̸ç ȯºÒÀº ¹ÝǰµµÂøÀϷκÎÅÍ ¿µ¾÷ÀÏ ±âÁØ 3ÀÏ À̳»¿¡ ¿Ï·áµË´Ï´Ù.
      ´Ü¼øº¯½É ¹×
      ÁÖ¹®Âø¿ÀÀÇ °æ¿ì
      1) ½Å¼±½Äǰ, ³ÃÀå½Äǰ, ³Ãµ¿½Äǰ
      ÀçÆÇ¸Å°¡ ¾î·Á¿î »óǰÀÇ Æ¯¼º»ó, ±³È¯ ¹× ȯºÒÀÌ ¾î·Æ½À´Ï´Ù.
      2) È­Àåǰ
      ÇǺΠƮ·¯ºí ¹ß»ý ½Ã Àü¹®ÀÇ Áø´Ü¼­ ¹× ¼Ò°ß¼­¸¦ Á¦ÃâÇϽøé ȯºÒ °¡´ÉÇÕ´Ï´Ù. ÀÌ °æ¿ì Á¦¹Ýºñ¿ëÀº ¼ÒºñÀÚ ºÎ´ãÀ̸ç, ¹è¼Ûºñ´Â ÆÇ¸ÅÀÚ°¡ ºÎ´ãÇÕ´Ï´Ù. ÇØ´ç È­Àåǰ°ú ÇǺΠƮ·¯ºí°úÀÇ »ó´çÇÑ Àΰú°ü°è°¡ ÀÎÁ¤µÇ´Â °æ¿ì ¶Ç´Â Áúȯġ·á ¸ñÀûÀÇ °æ¿ì¿¡´Â Áø´Ü¼­ ¹ß±Þºñ¿ëÀ» ÆÇ¸ÅÀÚ°¡ ºÎ´ãÇÕ´Ï´Ù.
      3) ±âŸ »óǰ
      ¼ö·ÉÀϷκÎÅÍ 7ÀÏ À̳» ½Åû, ¿Õº¹¹è¼Ûºñ´Â ¼ÒºñÀÚ ºÎ´ã
      4) ¸ð´ÏÅÍ ÇØ»óµµÀÇ Â÷ÀÌ·Î »ö»óÀ̳ª À̹ÌÁö°¡ ´Ù¸¥ °æ¿ì ´Ü¼øº¯½É¿¡ ÀÇÇÑ ±³È¯ ¹× ȯºÒÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.
      ±³È¯ ¹× ȯºÒ ºÒ°¡ 1) ½Åû±âÇÑÀÌ Áö³­ °æ¿ì
      2) ¼ÒºñÀÚÀÇ °ú½Ç·Î ÀÎÇØ »óǰ ¹× ±¸¼ºÇ°ÀÇ Àüü ¶Ç´Â ÀϺΰ¡ ¾ø¾îÁö°Å³ª ÈѼÕ, ¿À¿°µÇ¾úÀ» °æ¿ì
      3) °³ºÀÇÏ¿© ÀÌ¹Ì ¼·ÃëÇÏ¿´°Å³ª »ç¿ë(Âø¿ë ¹× ¼³Ä¡ Æ÷ÇÔ)ÇØ »óǰ ¹× ±¸¼ºÇ°ÀÇ °¡Ä¡°¡ ¼Õ»óµÈ °æ¿ì
      4) ½Ã°£ÀÌ °æ°úÇÏ¿© »óǰÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
      5) »ó¼¼Á¤º¸ ¶Ç´Â »ç¿ë¼³¸í¼­¿¡ ¾È³»µÈ ÁÖÀÇ»çÇ× ¹× º¸°ü¹æ¹ýÀ» ÁöŰÁö ¾ÊÀº °æ¿ì
      6) »çÀü¿¹¾à ¶Ç´Â ÁÖ¹®Á¦ÀÛÀ¸·Î ÅëÇØ ¼ÒºñÀÚÀÇ ÁÖ¹®¿¡ µû¶ó °³º°ÀûÀ¸·Î »ý»êµÇ´Â »óǰÀÌ ÀÌ¹Ì Á¦ÀÛÁøÇàµÈ °æ¿ì
      7) º¹Á¦°¡ °¡´ÉÇÑ »óǰ µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì
      8) ¸À, Çâ, »ö µî ´Ü¼ø ±âÈ£Â÷ÀÌ¿¡ ÀÇÇÑ °æ¿ì